Top Story

American Indians, Alaskan Natives experienced shorter cancer survival, even with equal access to care

November 21, 2014

Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites even when they had equal access to health care, according to study results presented at the American Association for Cancer Research Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved in San Antonio.

Marc A. Emerson, MPH, cancer research training award fellow in the division of cancer control and population sciences at the NCI, and colleagues used Kaiser Permanente Northern California electronic health records to collect data on 1,022 American Indians and Alaskan Natives diagnosed with primary invasive cancer between 1997 and 2012.

Meeting News Coverage

Stereotactic radiation improved local control in inoperable SCLC

November 20, 2014
Stereotactic body radiotherapy using 50 Gy in five fractions appears to achieve outstanding long-term local control in patients with medically inoperable small cell lung…
Madhusmita Behera, PhD Meeting News Coverage

Tumor subclassification provided no additional survival benefit in lung adenocarcinomas

November 19, 2014
Overall and 5-year survival rates are similar between lung cancer patients with minimally invasive adenocarcinoma and those with adenocarcinoma in situ, according to…
In the Journals

Patients with lung, colon cancers often not informed about clinical trials

November 17, 2014
The majority of patients with newly diagnosed lung or colorectal cancers do not have discussions with their care team about clinical trial participation, according to…
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage

American Indians, Alaskan Natives experienced shorter cancer survival, even with equal access to care

November 21, 2014
Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites…
Meeting News Coverage

Stereotactic radiation improved local control in inoperable SCLC

November 20, 2014
Stereotactic body radiotherapy using 50 Gy in five fractions appears to achieve outstanding long-term local control in patients with medically…
Madhusmita Behera, PhD Meeting News Coverage

Tumor subclassification provided no additional survival benefit in lung adenocarcinomas

November 19, 2014
Overall and 5-year survival rates are similar between lung cancer patients with minimally invasive adenocarcinoma and those with adenocarcinoma in…
In the Journals

Patients with lung, colon cancers often not informed about clinical trials

November 17, 2014
The majority of patients with newly diagnosed lung or colorectal cancers do not have discussions with their care team about clinical trial…
In the Journals

One-third of UK patients diagnosed with lung cancer die within 3 months

November 14, 2014
Nearly one in three patients with lung cancer in the United Kingdom die within 3 months of diagnosis, despite consulting their primary care…

10 issues to consider during National Lung Cancer Awareness Month

November 12, 2014
Accounting for more annual deaths than colon, breast and prostate cancers combined in the United States, lung cancer is the leading cause of…
Roy S. Herbst, MD, PhD Health PolicyPerspective

CMS supports Medicare coverage of lung cancer screening

November 10, 2014
The CMS today issued draft guidance that supports Medicare coverage of annual lung cancer screening with low-dose CT for individuals who meet…
William C. Black, MD In the Journals

Lung cancer screening would cost $81,000 per quality-adjusted life-year gained

November 5, 2014
The cost-effectiveness of lung cancer screening with low-dose CT — estimated to cost $81,000 for each quality-adjusted life-year gained — is highly…
Paul G. Walfish Meeting News Coverage

Painless thyroiditis syndrome associated with PD-1 treatment in patients with cancer

November 1, 2014
CORONADO, Calif. — A small subset of patients with metastatic malignancies who received immunotherapy with program death-1 receptor monoclonal…
David Gerber, MD In the Journals

Lung cancer clinical trials routinely exclude cancer survivors

October 31, 2014
Many patients are automatically excluded from lung cancer clinical trials due to previous cancer, according to findings.Additionally, this criterion…
More Headlines »
morganatic-roan
morganatic-roan